Joseph E Sundeen

This inventor holds 55 USPTO granted patents, plus 2 CIPO patents, primarily in Beta-Lactam Antibiotics (CPC class 2602). Top assignees: E. R. Squibb Sons, Inc., Bristol-Myers Squibb Compnay. Active years: 1976-2006.

USPTO Granted Patents = 55

% Patents Active = 96.4

CIPO Patents = 2 (Patent Applications = 6)

Average Co-Inventor Count = 2.6

ph-index = 8

Forward Citations = 254(Granted Patents)

Forward Citations (Not Self Cited) = 222(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Trenton, NJ (US) (1976 - 1977)
Yardley, PA (US) (1976 - 2006)

Company Filing History:

46 out of 1,624

E. R. Squibb Sons, Inc.

patents

9 out of 3,735

Bristol-Myers Squibb Compnay

patents

Years Active: 1976-2006

Loading Chart...

Areas of Expertise:

Beta-Lactam Antibiotics

Mammalian Collagenase Inhibitors

Azacycloalkanoylaminothiazoles

Pyrrolotriazine Kinase Inhibitors

Chiral Cyclopropane Carboxylic Acids

Monobactam Hydrazides

Heteroaryl Derivatives

ACE-Diuretics

Inhibitors

Substituted Chromans

Prostaglandin Inhibitors

Indanpentol Derivatives

55 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7034151 - Process for preparing pyrrolotriazine kinase inhibitors (2006-04-25),

2. 6897321 - Process for preparing azacycloalkanoylaminothiazoles (LD 137e) (2005-05-24),

3. 6639074 - Process for preparing azacycloalkanoylaminothiazoles (2003-10-28),

4. 6613911 - Process for preparing arylacetylaminothiazoles (2003-09-02),

5. 6562994 - Process for the preparation of N-(substituted phenyl)-3-alkyl-,aryl- and heteroarylsulfonyl-2-hydroxy-2-alkyl- and haloalkylpropanamide compounds (2003-05-13),

6. 6414156 - Process for preparing azacycloalkanoylaminothiazoles (2002-07-02),

7. 6392053 - Process for preparing arylacetylaminothiazoles (2002-05-21),

8. 6160134 - Process for preparing chiral cyclopropane carboxylic acids and acyl (2000-12-12),

9. 6100395 - Reductive alkylation of secondary amines with hydrosilane (2000-08-08),

10. 5705645 - Hereroaryl derivatives of monocyclic beta-lactam antibiotics (1998-01-06),

11. 5420277 - Intermediates for the preparation of heteroaryl derivatives of (1995-05-30),

12. 5290929 - Heteroaryl derivatives of monocyclic beta-lactam antibiotics (1994-03-01),

13. 5143913 - [3S(Z)]-3-[[(2-amino-4- (1992-09-01),

14. 5077432 - Monobactam hydrazides containing catechol sulfonic acid groups (1991-12-31),

15. 5037983 - 6,7-dihydroxyquinoxalines as intermediates to beta-lactam antibiotics (1991-08-06),

Title: The Innovative Journey of Joseph E. Sundeen

Introduction: Joseph E. Sundeen, a pioneering inventor based in Yardley, PA (US), has made significant contributions to the world of innovations with his groundbreaking ideas and inventions.

Latest Patents: Joseph E. Sundeen holds several patents in various fields, including technology, healthcare, and consumer products. His most recent patents focus on advancements in renewable energy solutions and sustainable packaging materials.

Career Highlights: With a career spanning over two decades, Joseph E. Sundeen has established himself as a visionary inventor known for his ability to transform ideas into tangible solutions. His work has not only revolutionized industries but has also improved the quality of life for many.

Collaborations: Throughout his career, Joseph E. Sundeen has collaborated with leading research institutions, universities, and innovative companies to bring his inventions to life. His collaborative spirit and passion for innovation have led to the successful development of cutting-edge technologies.

Conclusion: Joseph E. Sundeen's relentless pursuit of innovation and his dedication to creating a positive impact on society have solidified his position as a respected inventor in the field. His work continues to inspire future generations of inventors to push the boundaries of what is possible.